Avelumab as neoadjuvant therapy in patients with urothelial non-metastatic muscle invasive bladder cancer: a multicenter, randomized, non-comparative, phase II study (Oncodistinct 004 - AURA trial)

Peer Review reports

Original Submission
30 Sep 2020	Submitted	Original manuscript
17 Jul 2021	Reviewed	Reviewer Report
7 Aug 2021	Reviewed	Reviewer Report
18 Oct 2021	Author responded	Author comments - Nieves Martinez Chanza
Resubmission - Version 2
18 Oct 2021	Submitted	Manuscript version 2
5 Nov 2021	Author responded	Author comments - Nieves Martinez Chanza
Resubmission - Version 3
5 Nov 2021	Submitted	Manuscript version 3
Publishing
10 Nov 2021	Editorially accepted
2 Dec 2021	Article published	10.1186/s12885-021-08990-3

Back to article page